European cluster collaboration delivers promising results for innovation in life sciences and biotech
For two years, Danish Life Science Cluster and 5 other European clusters have collaborated to streamline and accelerate innovation among companies and researchers in Europe. Read about the promising results from the Horizon Europe (EIE) INNAXE project.
Danish Life Science Cluster has just received the highest European recognition for the cluster’s work. Still, we constantly strive to become even better at creating innovation and collaborations to benefit companies and the health sector.
We do this by working closely with other European clusters.
“We must constantly strengthen our skills to facilitate innovation, and therefore it is important that we learn from the best in Europe,” says Karen Lindegaard, international programme manager at Danish Life Science Cluster.
A pan-European cooperation is now ready with promising results. The INNAXE consortium has worked to strengthen and streamline a European innovation community for companies, research environments, health professionals and patient organisations in the life sciences and biotech sectors.
Working together for European engagement and impact
The INNAXE consortium consists of six European partners: BIOCAT, Medicen Paris Region, BioRN, Health & Life Sciences Cluster Bulgaria, Council of European BioRegions and Danish Life Science Cluster.
The six partners met and presented the project’s results in connection with the Spinoff Bulgaria conference in June 2024. Here, the consortium was able to highlight three significant results in particular:
1) Engagement of European actors – including
- 31 meetings with leading European opinion leaders,
- 91 responses from European SMEs, researchers and health professionals in joint survey
- 79 participants in co-creation activities
2) Reflections on sustainable results: The consortium has developed a ‘Joint Programme’, which based on nine selected topics will ensure collaboration between the clusters for the next five years.
3) Long-term effect: Although the project officially ends in June 2024, the consortium members/partners will continue to ensure the project’s impact in the coming years.
Read more: Executive summary – 9 activities for European Life Science Actors – for long-term collaboration and impactIn addition, INNAXE has analysed which actions create value for the benefit of the European life science ecosystem. The results are compiled in the ‘Guidelines for Ecosystem Monitoring, Benchmarking, and Impact Evaluation Results. You can download the analysis for free here.
Read more about the project and find further material here.
INNAXE is co-financed by the European Union.
